Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

计划入组 390 人 · 首次发布于 2020 年 11 月 24 日

Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

计划入组 29 人 · 首次发布于 2021 年 11 月 26 日

SF4 (Meiji Seika Pharma Co., Ltd.)

B-3 (Meiji Seika Pharma)

B-3 (Meiji Seika Pharma/Juntendo University)

MEIJI SEIKA PHARMA CO., LTD.

Japan

Meiji Seika Kaisha Ltd.

Japan

MEIJI CO., LTD.

Japan

Meiji Seika Pharma Partners with MBC BioLabs to Accelerate Drug Discovery Innovation

Meiji Seika Pharma Launches Phase I Trial of ME3241, Novel PD-1 Agonist for Autoimmune Diseases

Osivax Raises €10M in Series B Funding to Advance Broad-Spectrum Influenza Vaccine Development